Development of a ‘universal-reporter’ outcome measure (UROM) for patient and healthcare professional completion : a mixed methods study demonstrating a novel concept for optimal questionnaire design by Macefield, Rhiannon C. et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Manuscript version: Author’s Accepted Manuscript 
The version presented in WRAP is the author’s accepted manuscript and may differ from the 
published version or Version of Record. 
 
Persistent WRAP URL: 
http://wrap.warwick.ac.uk/123726                                                       
 
How to cite: 
Please refer to published version for the most recent bibliographic citation information.  
If a published version is known of, the repository item page linked to above, will contain 
details on accessing it. 
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  
 
Copyright © and all moral rights to the version of the paper presented here belong to the 
individual author(s) and/or other copyright owners. To the extent reasonable and 
practicable the material made available in WRAP has been checked for eligibility before 
being made available. 
 
Copies of full items can be used for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge. Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
Please refer to the repository item page, publisher’s statement section, for further 
information. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk. 
 
 1 
 
Development of a ‘universal-reporter’ outcome measure (UROM) for patient 
and healthcare professional completion: a mixed methods study demonstrating 
a novel concept for optimal questionnaire design 
 
 
Rhiannon C Macefield1, Sara T Brookes1, Jane M Blazeby1,2, Kerry N L Avery1 on behalf of the Bluebelle 
Study Group*  
 
1The MRC ConDuCT-II Hub for Trials Methodology Research, Bristol Medical School, University of Bristol, 
UK 
 
2Division of Surgery, Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol Royal 
Infirmary, Bristol, UK 
 
Corresponding author: 
Ms Rhiannon Macefield 
Bristol Medical School 
University of Bristol 
Canynge Hall, 39 Whatley Road 
Bristol BS8 2PS 
(0)117 928 7367 r.macefield@bristol.ac.uk 
  
 2 
 
Abstract 
Objectives: To describe the novel concept of, and methods for developing, a ‘universal-reporter’ 
outcome measure (UROM); a single questionnaire for completion by patients and/or healthcare 
professionals (HCPs) when views on the same subject are required.   
Design: A mixed methods study with three phases – Phase 1) identification of relevant content domains 
from existing clinical tools, patient questionnaires and in-depth interviews with multi-stakeholders; 
Phase 2) item development using a novel approach: plain language in conjunction with medical 
terminology; and Phase 3) pre-testing with multi-stakeholders using cognitive interviews.  
Setting: A case study in surgical wound assessment undertaken in two UK hospital trusts and one 
university setting. 
Participants: Patients who had recently undergone general abdominal surgery and healthcare 
professionals involved in post-surgical wound care. 
Results: Phase 1) In the example case study, 19 relevant content domains were identified from two 
clinical tools, two patient questionnaires and 19 multi-stakeholder interviews (9 patients, 10 HCPs). 
Phase 2) Domains were operationalised into 16 initial items. Plain language in conjunction with medical 
terminology was applicable in nine (27%) items. Phase 3) Pre-testing with 28 patients and 14 HCPs found 
that the UROM was acceptable to both respondent groups. An unanticipated secondary finding of the 
study was that the combined use of plain language and medical terminology during questionnaire 
development may be a useful, novel technique for evaluating item interpretation and thereby 
identifying items with inadequate content validity.  
Conclusion: UROMs are a novel approach to outcome assessment that are acceptable to both patients 
and HCPs. Combining plain language and medical terminology during item development is a 
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recommended technique to improve accuracy of item interpretation and content validity during 
questionnaire design. More work is needed to further validate this novel approach and explore the 
application of UROMs to other settings.  
 
Keywords  
Outcome measurement, questionnaire development, content validity, item construction, patient-
reported outcome.  
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Strengths and limitations of this study 
 A novel approach to outcome assessment is described, comprising the use of plain language 
alongside medical terminology in questionnaire items to develop a single measure for 
completion by patients and/or healthcare professionals; 
 Multiple stakeholders were considered in all phases of development of the new outcome 
measure; 
 Methods to develop UROMs present a novel technique for evaluating item interpretation and 
improving content validity during questionnaire development;  
 Evaluation of this novel method is limited to the findings from a single case study. Further work 
is warranted to explore the applicability of UROMs to other settings.  
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Background 
Research often requires views from different stakeholders on the same subject. Reasons may be to 
combine different stakeholder responses, in order to obtain comprehensive information to better 
answer the research question. Other reasons may be to compare stakeholder responses and explore any 
similarities or differences in perspectives, opinions or behaviours. Alternatively, there may be logistical 
reasons for obtaining views from different stakeholders, to enable important data to be collected 
irrespective of who is available to provide it. In a clinical trial, for example, the frequency and severity of 
symptoms and adverse events might be self-reported by the patient and/or judged by an observer, such 
as a healthcare professional (HCP) [1,2]. In these situations, assessment tools and questionnaires are 
usually developed separately for use by a specific stakeholder group. Consequently, two different 
tools/questionnaires that intend to measure the same construct (concept) may use different 
terminology to suit the target audience. In the assessment of wounds for surgical site infection, for 
example, there are tools for clinical staff that use medical terminology such as ‘purulent drainage’ and 
‘spontaneous dehiscence’. Alternatively, separate patient-completed questionnaires use plain language 
descriptions asking patients, for example, about ‘discharge or leakage of fluid’ and whether the ‘edges 
of the wound separated or gaped open’. 
While separate stakeholder-specific tools may intend to measure the same constructs, uncertainty 
remains about whether this is achieved in practice. Evidence suggests that even minor alterations to 
item (question) wording can lead respondents to draw on different sources of information, subsequently 
affecting their responses [3,4]. It is likely, therefore, that the use of different stakeholder-specific 
terminology in separate tools for patients and for HCPs that intend to measure the same construct may 
introduce a degree of variation in the way that they are interpreted and subsequently the response that 
is provided. Specifically, differential understanding of items between individual respondents or 
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stakeholder groups can compromise the measure’s content validity or degree to which the content 
adequately reflects the construct being measured. This can have implications for drawing accurate 
conclusions when combining or comparing data collected from different stakeholder groups. Equitable 
interpretation of items by different respondents is therefore essential to ensure that the data collected 
by the separate measures are accurate and valid. It is hypothesised that developing a universal-reporter 
outcome measure (UROM) which uses a single set of terminology to collect data from either patients 
and/or HCPs may reduce variation in interpretation and thereby optimise the content validity of the 
measure. This study introduces the concept and method for developing a UROM, illustrated within a 
case study of surgical wound assessment. 
 
Methods 
Case study: Development of an outcome measure for surgical site infection (SSI) 
The concept of a UROM originated as a solution to a problem within a feasibility study of surgical wound 
assessment. The feasibility study was performed to explore whether it would be possible to conduct a 
large randomised controlled trial (RCT) of different wound dressing strategies. The proposed primary 
outcome of the main RCT was surgical site infection (SSI) at 30 days post-surgery [5]. Assessment of SSI 
at this timepoint would typically be after the patient had been discharged from hospital and was 
recovering at home. At the time of the feasibility study, separate stakeholder-specific tools for 
evaluating surgical wounds to assess SSI were available for HCPs and for patients though they had 
several limitations [6-10]. The clinical tools for HCPs to complete, for example, were designed for use 
while patients were still in hospital, predominately used medical terminology and were complex to 
complete [6,8]. The questionnaires for patients were developed from a clinical perspective, did not 
involve patients in their development and had not been formally validated [7,9]. One aim of the 
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feasibility study, therefore, was to develop and validate an outcome measure assess wounds for 
infection that was suitable for use both in-hospital after the patient had been discharged. While it would 
have been possible to develop two separate stakeholder-specific measures, it was recognised that this 
may compromise the validity with which the construct of SSI was measured. A single UROM to evaluate 
surgical wounds, suitable for completion by patients or HCPs, was therefore developed. 
 
Development of the universal-reporter outcome measure 
The UROM was developed using established methods for developing new outcome measures [11,12] 
adapted to address specific issues relevant to developing a UROM (Table 1). The following sections 
provide a brief description of these unique considerations and adapted methods, drawing on the 
surgical wound case study as an example. A full description of the development and evaluation of the 
surgical wound outcome measure (including assessments of reliability, a comparison of patient and HCP 
responses, and clinical validity) has been published elsewhere [13,14] and is outside the scope of this 
paper. 
Table 1. Phases of UROM development  
 Established methods for outcome 
measure development 
Adapted/novel methods relevant to UROM 
development 
Phase 1  Identification of content domains  Emphasis on using a multi-stakeholder 
perspective to identify domains of importance 
Phase 2  Item construction  A multi-stakeholder approach considering plain 
language in conjunction with medical 
terminology 
Phase 3  Pre-testing and evaluation of content 
validity 
Cognitive interviews with multiple stakeholders 
 
Phase 1) Identification of content domains using a multi-stakeholder perspective 
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The first phase in the development of any new measurement instrument typically involves the 
identification of important content domains (i.e. areas of interest potentially relevant to include in the 
new tool). Typical sources include the existing literature, and interviews with key stakeholders to elicit 
expert opinion and experience [12]. The focus of the UROM development was to consider patient and 
HCP perspectives together to identify domains of importance to either or both stakeholders, for 
consideration to include in a single tool.  
In the case study, health domains (defined as the sign, symptom or wound care intervention relevant to 
SSI assessment and management) important to patients and HCPs for possible inclusion in the new SSI 
measure were identified using existing guidelines for questionnaire development [15,11]. First, a 
content analysis of the two most commonly used existing clinical tools identified in a previous 
systematic review [16], and their two associated patient questionnaires, was undertaken. In addition, in-
depth interviews with 19 stakeholders were conducted; nine patients who had experience of wound 
infection and ten HCPs involved in post-surgical care. Details of the existing tools, the methods for 
analysing their content, and the interview sampling strategy and data collection have previously been 
reported [13]. Importantly for the UROM, data from the analysis of existing tools and interviews were 
combined to provide a list of all the domains considered to be relevant to SSI assessment, irrespective of 
whether the source was from a patient’s and/or a HCP’s perspective.  
 
Phase 2) Item construction using a multi-stakeholder approach; considering plain language in 
conjunction with medical terminology 
The second phase in the development of a new measure instrument usually involves the conversion or 
‘operationalisation’ of domains (identified in Phase 1) into items for a questionnaire. For the UROM, a 
novel approach was applied to item construction; using both plain language and medical terminology 
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wherever possible. The reason for doing this initially was to use language that was understood by, and 
was familiar to, each stakeholder group, to facilitate easy and timely completion of the outcome 
measure.  
In the case study, the list of important SSI domains identified in Phase 1 were considered for inclusion in 
the UROM. Domains considered to be unsuitable for patient-report were excluded. Item construction 
was performed by four members of the case study team (JMB, RM, TM, BR), experts in the design and 
use of questionnaires including patient-reported outcome measures, and professionals in the clinical 
field. First, plain language was used to describe the SSI domain in a clear and unambiguous way. 
Language was targeted for a lay audience without technical or medical terms, following standard 
recommendations [12,15,17]. Next, medical terminology (if it existed) relating to the SSI domain was 
included in parentheses at the end of the item. An example is illustrated in Box 1.  
 
Box 1. Example item showing plain language with medical terminology in parentheses
 
 
Response categories took the form of either a binary yes/no response or an ordinal scale (initially a five-
point scale ‘not at all’, ‘a little’, ‘moderately’, ‘quite a bit’ and ‘very much’) as appropriate to the 
individual item. The remaining structure and layout of the questionnaire was designed to be simple, 
clear and straightforward for patients and/or HCPs to complete, in accordance with established 
guidelines. The UROM was produced in two formats. One format was a paper-copy questionnaire to 
post to patients after leaving hospital. The other format was a paper-copy case report form (CRF) for 
HCPs to complete when conducting observer wound assessments either on the telephone or face-to-
Was there redness spreading away from the wound? (erythema/cellulitis) 
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face as part of the wider feasibility study. Items and response categories were identical. The only minor 
difference was the use of first-person or third-person narrative, necessary for whether the tool was to 
be completed by a patient or an observer (Box 2).  
 
Box 2. Example item showing first-person and third-person narrative
 
 
Phase 3) Pre-testing and evaluation of content validity: cognitive interviews with multiple 
stakeholders  
The third phase in the development of a new measurement involves pre-testing with a sample of 
participants from the target population. Asking potential recipients to complete early drafts of a new 
measurement instrument is critical for testing understanding, interpretation and identifying potential 
problems with its completion and use. Cognitive interviews are a valuable technique used during pre-
testing to examine content validity and ensure that items are comprehended as intended [12,18]. Pre-
testing of the case study outcome measure has previously been described in detail [13]. Methods of 
specific relevance to development of the UROM are reprised and expanded below. 
 
Participants and recruitment 
In the case study, both patients and HCPs were invited to take part in cognitive interviews to pre-test 
early versions the measure. Patients were those who had recently undergone general abdominal 
surgery, identified and approached by research nurses/members of the study team in two UK hospital 
Has your wound been drained? (drainage of pus/abscess) 
Has the wound been drained? (drainage of pus/abscess) 
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trusts. Healthcare professionals were those involved in post-surgical care, identified from the same 
hospital trusts and from the authors’ university institution. Written information describing the study in 
detail was provided to all participants. Contact details of interested participants were passed on to 
members of the study team and followed up by telephone or email to further discuss the study, answer 
questions and arrange an interview. Interviews were conducted by two researchers (RM and TM) 
between January and August 2015. Written consent was obtained prior to each interview. Ethical 
approval was provided by the NHS Health Research Authority NRES Committee London - Camden & 
Kings Cross (14/LO/0640). 
Cognitive interviews  
Individual face-to-face cognitive interviews were conducted with participants in order to explore the 
overall acceptability, suitability and comprehensibility of the early versions of the UROM. The primary 
aim of the interviews was to examine the suitability of the UROM as an outcome measure for SSI. 
Specific objectives were to refine aspects of the questionnaire, including the layout, item phrasing, 
instructions and response categories. Additionally, and of specific relevance to development of a UROM, 
interviews explored views on items that included both plain language and medical terminology.  
 
Participants were shown the questionnaire and asked to complete the items relating to their current 
experience (patients) or a recent or hypothetical patient case (HCPs). Participants were asked to vocalise 
their thoughts as they read and responded to each item using a ‘think aloud’ technique [18]. Completion 
of the questionnaire was observed by the researcher who then use probing questions to explore the 
participants’ thoughts in more depth. Interpretation, accuracy and general opinions on the use of 
medical terminology alongside plain language in the questionnaire were sought. Question probes, for 
example, asking HCPs “Is [the plain language] a suitable description of the medical term?” were used to 
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explore the accuracy of the item for measuring the intended underlying construct. Areas for 
investigation and specific items for discussion were identified and evolved throughout the course of 
interviews. Revisions were made to the provisional draft and new versions tested in subsequent 
interviews with new participants until findings indicated that no further revisions were required. 
 
Data analyses 
Interviews were audio-recorded and written up in descriptive memoranda summarising key findings and 
suggestions for improvements to the questionnaire. Selected relevant quotations were transcribed 
verbatim. Interviews, analyses and modifications to the questionnaire were performed as an iterative 
process so that revisions to the questionnaire could be explored in subsequent interviews. Two 
researchers (RM and TM) independently conducted and summarised interviews, cross-checking 
approximately 25% of audio-recordings and memoranda to maximise rigour and reliability of the 
findings [19]. 
 
Patient and public involvement 
Patients and members of the public were involved throughout the study. Two patient and public 
representatives were included on the study steering committee. A meeting was held with a group of 
patients to discuss the design and conduct of the study and to refine patient-facing study documents. 
 
Results 
Phase 1) Identification of content domains using a multi-stakeholder perspective 
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In the case study, 19 relevant content domains (covering SSI signs, symptoms and wound care 
interventions) were identified from the existing tools and in-depth interviews (Table 2). Of these 19 
domains, 18 were identified from the existing clinical tools and/or patient questionnaires and were 
supported by interview data. One domain (smell) was not identified in existing tools, but was found to 
be important in interviews with both patients and HCPs.  
Table 2. Identified domains of importance for inclusion in the case study UROM for surgical wound 
assessment 
 Existing tool 
Domain relevant to SSI assessment 
Patient 
questionnaire 
Clinical tool 
1. Wound healing  x 
2. Wound heat  x 
3. Wound redness   
4. Wound discharge  
 
  
5. Layers separating - 
spontaneous 
  
6. Wound swelling   
7. Wound pain   
8. Fever x  
9. Contact with healthcare 
professional 
 x 
10. Dressing needed  x 
11. Antibiotics needed   
12. Layers separating - deliberate x  
13. Hospital admission  x 
14. Drainage needed x  
15. Wound cleaning   
16. Abscess   
17. Microbiology   
18. Prolonged hospital stay x  
19. Smell* x x 
*identified from stakeholder interviews 
Phase 2) Item construction using a multi-stakeholder approach; considering plain language in 
conjunction with medical terminology 
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Seventeen of the 19 domains identified in Phase 1 were developed into items for the first draft of the 
UROM. Two domains were excluded (microbiology and prolonged hospital stay) as they were 
considered unsuitable for patient-report, and information could more reliably be obtained through 
other sources (e.g. hospital records). All items were intended to be completed by all respondents, with 
some items having secondary components (sub-items) to collect further information, where relevant. 
For example, if a participant responded to an item indicating that a symptom was present, further 
questions captured more details about that symptom.  
The first draft of the UROM prior to pre-testing included 13 items, of which six included secondary sub-
items to collect further information. Eight medical terms were included in parentheses after the plain 
language either in the items or secondary sub-items. It was not applicable to include medical 
terminology in the remaining items because a medical description did not exist for the construct being 
addressed; for example, ‘Has the wound been smelly?’. In the first draft, eight items had ordinal 
response categories and five items had binary yes/no response options. Responses of ‘don’t know’ were 
also included to explore whether participants required this option and identify potentially problematic 
items to answer. 
 
Phase 3) Pre-testing and evaluation of content validity: cognitive interviews with multiple 
stakeholders 
Forty-two cognitive interviews (with 28 patients and 14 HCPs) were conducted. Participant 
characteristics and interview duration are summarised in Table 3.  
Detailed findings from the pre-testing phase of the case study SSI outcome measure have previously 
been reported [13]. Findings of particular relevance to UROM design are described in detail below.  
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Table 3. Participant demographics and interview duration 
 Number of 
participants 
(Total n=42) 
Patients, n (%) 28 (66.7) 
HCPs, n (%) 14 (33.3) 
Age, years (%)  
21-30 1 (2.4) 
31-40 9 (21.4) 
41-50 5 (11.9) 
51-60 9 (21.4) 
>60 18 (42.9) 
Male, n (%) 21 (50.0) 
Clinical expertise*  
General practitioner 3 (21.4) 
Hospital/Research nurse/midwife 4 (28.6) 
Practice/Community nurse/midwife 3 (21.4) 
Surgical trainee 4 (28.6) 
Surgery type**, n (%)  
Caesarean section 3 (10.7) 
Upper GI † 9 (32.1) 
Lower GI 10 (35.7) 
Hernia repair 6 (21.4) 
Duration of interview, minutes  
Median (range) 25 (13 to 52) 
*HCP participants only, **patient participants only, †gastro-intestinal 
 
1. Modifications to the UROM during pre-testing 
Throughout pre-testing and the iterative process of interviews and revisions, the UROM was modified 
eight times. The final version after pre-testing included 16 items for assessing SSI, with five having 
secondary sub-items to collect further information. Nine medical terms were included in parentheses at 
the end of items (supplementary file 1).  
 
General modifications (not specific to UROM design) included revision of the ordinal response categories 
from a five-point to a four-point scale (‘not at all’, ‘a little’, ‘quite a bit’ and ‘a lot’) because a middle 
 16 
 
category of ‘moderately’ was found to be uninformative. The filter question at the beginning of the 
measure (“Have you had any problems with the healing of your wound(s)?”) was also dropped because 
data indicated that participants’ answers to this filter question were often not concordant with their 
subsequent responses to subsequent items (e.g. participants responded that they had no problems with 
wound healing, but went on to report experiencing symptoms of problems with wound healing). 
General changes also included restructuring some items, for example, changing some secondary sub-
items to standalone items to minimise errors and reduce missing data. 
Several changes were made to the provisional measure of specific relevance to UROM design. Most 
changes related to the use of plain language in conjunction with medical terminology. For example, one 
medical term (calor) was dropped as interviews revealed it was not a term that was used in current 
practice. Another medical term (spontaneous dehiscence) was added to an item where previously no 
medical description had been considered. Detail explaining the reason for this is provided below. In 
another item, one term (dressing) that was initially included in the plain language description was later 
moved to the end of the item in parentheses because interviews revealed that it was less understood by 
a lay audience than initially expected.  
 
2. Acceptability of UROMs and items combining plain language and medical terminology 
In general, neither patients nor HCPs reported significant concerns with the inclusion of medical 
terminology alongside plain language within the same item. Some patients reported that they found the 
medical terms interesting and educational. Other patients reported that they found sufficient for 
comprehension and therefore only read the plain language and ignored or did not notice the medical 
terms (Box 3). Concerns that medical terms may cause patients anxiety was raised in interviews with 
HCPs, although this was not supported by data from interviews with patients. One patient referred to 
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the use of the internet to look up medical terms but did not express any concerns about doing so (Box 
3). 
 
Box 3: acceptability of items combining plain language and medical terminology  
 
 
3. Improved understanding and interpretation of items 
An unanticipated secondary unexpected finding of the study was that the combined use of plain 
language and medical terminology may be a useful, novel technique for evaluating item understanding 
and improving item interpretation during the process of developing the measure. Findings from the pre-
testing interviews indicated that the inclusion of a medical term alongside plain language in an item 
directly affected the way that participants interpreted and subsequently responded to items, by 
Participant: “I just skipped over it… I did say ‘What’s that?’ but it didn’t concern me because I 
could answer the question… I did make the comment of what [is that] but I didn’t worry about 
it and I just went on to the next bit.” 
Patient participant, 1107 
 
 
Participant: “I was... you know... interested [in the medical terms]. I didn’t look at all of it… um, 
a couple I thought was interesting because it was Latin. That’s what I thought. And also 
spontaneous dehiscence... I thought, gosh… so yeah I found it quite interesting.” 
 
Interviewer: “Did you find them[medical terms] confusing?” 
 
Participant: “No… For instance that first one… I don’t think I even saw… ” 
 
Patient participant, 1104 
 
 
Participant: “If I was... on my own receiving this I am a bit of a google searcher so I would 
probably have looked them up.” 
Patient participant, 2030 
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facilitating their understanding of the item. One participant, for example, explained how the presence of 
the medical term improved their understanding of the item, thereby enabling them to respond more 
accurately. This participant reported that they would have interpreted the item differently, and 
therefore responded differently, had the medical term not been included (Box 4). 
Box 4: improved understanding and interpretation of items
 
 
4. Identification of items with inadequate content validity 
Directly related to the finding that the use of plain language and medical terminology may improve 
participants’ understanding and interpretation of items, the combined use of plain language and 
medical terminology during item development was found to be a useful technique to maximise the 
content validity of the outcome measure. The tandem use of medical terminology and plain language 
identified several items that were ambiguous or insufficiently reflected the construct that was intended 
to be measured. For example, it became apparent during interviews that some participants who read 
the plain language were interpreting an item differently to others who were also reading and 
understanding the medical terminology (Box 5). In this example, quotes from patient participants 
Item: Was there redness spreading away from the edges of the wound? (erythema and 
cellulitis) 
 
Participant: “In that first one [item], because I was describing the redness under the skin – more 
deeper redness, purple - when I read that first question, it was the fact that I had some idea of 
what erythema and cellulitis are… I thought, well it wasn’t those…but ended up saying a little 
because of the redness… it probably was erythema… but I wasn’t sure.”  
 
Interviewer: “And if we didn’t have that erythema and cellulitis in there?…” 
 
Participant: “Yeh, I would then have probably thought... that it was [asking about] that 
[bruising]... but because I recognised those [erythema and cellulitis]… I think I know more or 
less what those two things are.”  
Patient participant, 1081 
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demonstrated that the item was not being interpreted as intended, while quotes from the HCP 
participants indicated that the plain language description was not an adequate reflection of the medical 
terminology. This led to the item being modified to include more detail in the plain language description. 
Box 5: improved content validity of the construct to be measured 
 
 
In addition to the finding that using both plain language and medical terminology from the outset of 
item development may improve the content validity of the outcome measure, there was some evidence 
Item: Has your wound been cleaned out? (debridement of wound) 
 
Participant: “ [reading] ‘Has your wound been cleaned out?’... Yes it has been cleaned out...with 
this little plastic thing of liquid… saline stuff… They squirt this liquid in… put it on some gauze.” 
Patient participant, 1083  
 
Participant: “I think... urm… when I had the staples taken out I think it was pretty standard 
practice for the nurse to just clean the wound before.… I don’t know what she put on but it was a 
bit of cotton wool and she just rubbed… something.” 
Patient participant, 1104  
 
Participant: “To me… cleaned out and debridement… isn’t the same thing. Cleaned out is washing 
with saline and debridement is picking… slough… like yellow stuff out… or cutting dead skin away 
or scabs.” 
Healthcare professional participant, 3000 
Participant: “When you say cleaning out of the wound do you just mean, like, getting some 
water?...That [debridement] actually, to me, involves cutting… debridement is when you actually 
remove by cutting… or scraping… some dead tissue. Cleaned out, to me, just implies… oh, um, that 
you just gave it a bit of a clean… I completely understand what debridement of the wound means 
but, to me, cleaned out is not the same.” 
Healthcare professional participant, 1142 
 
Modified item: Has your wound been cleaned out to remove any dead tissue? (debridement of 
wound) 
 
  
 
  
 
Study 1 measure, V2.0 05/02/2015 
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to suggest that adding medical terminology to an item that had initially been written using only plain 
language may also maximise content validity. For example, interviews indicated that the plain language 
item ‘Have the edges of any part of the wound separated?’ was not specific enough for measuring the 
intended construct (cases where the wound had spontaneously broken down or ‘dehisced’). Specifically, 
the item was being interpreted too broadly by both patients and HCPs and was therefore interpreted to 
overlap with another later intended to measure the deliberate separation of the wound edges by a 
doctor or nurse (‘Has your wound been reopened by a doctor or nurse?’) (Box 6). A medical term 
(‘spontaneous dehiscence’) was added to this item and the plain language revised to ‘Have the edges of 
any part of the wound separated on their own accord’. Subsequent interviews with HCPs indicated that, 
had this medical term not been included, the plain language alone may not have been interpreted to 
include more serious cases of wound breakdown. 
Box 6: improved content validity of the construct to be measured 
 
 
  
Item: Have the edges of any part of the wound separated? 
 
Participant: “so what does that one mean?… so… it is separated… because it’s not stitched 
up”… The actual wound was left open because they couldn’t stitch it up.” 
Patient participant, 1079   
 
Participant: “What does that [separated] mean – like cut or something? Got bigger?” 
Patient participant, 1076  
 
Modified item: Have the edges of any part of the wound separated on their own accord? 
(spontaneous dehiscence) 
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Discussion 
This article describes the novel concept of, and a method for developing, a universal-reporter outcome 
measure (UROM). This is a single questionnaire developed to measure a construct using data collected 
from either patients and/or HCPs by using a single set of terminology comprising both plain language 
and medical terminology. A UROM may be required for logistical reasons (as in the example case study) 
or it may be for other purposes when there is a need to combine or compare responses from different 
stakeholders. Development of a UROM includes established methods for developing new outcome 
measures[11,12], uniquely adapted to address specific considerations and requirements of a UROM. 
These unique considerations include incorporating the views of all key stakeholders in all phases of 
UROM development and a novel approach to item construction by combining plain language alongside 
medical terminology. 
Illustrated within a case study of surgical wound assessment, the findings from this study indicate 
UROMs are acceptable for completion by both patients and HCPs and ready for further evaluation in 
future work. An unanticipated secondary finding of the study was that the combined use of plain 
language and medical terminology during questionnaire development may be a useful, novel technique 
for evaluating item interpretation and thereby identify items with inadequate content validity. 
Development and use of a UROM is recommended for studies where it is appropriate and beneficial to 
measure a construct using data collected from either patients and/or HCPs.  
The concept of a UROM, with items that combine plain language and medical terminology, represents a 
different approach to outcome measurement where traditionally tools for patients and HCPs are 
developed separately and used separately. Guidelines for the development of measurement 
instruments usually advise against the use of clinical or technical jargon (e.g. medical terminology), 
particularly when the general public are the intended recipients [20,12]. In general, guidance 
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recommends not to use medical terminology in patient literature, to avoid any difficulty in 
understanding [20-22]. This study shows, however, that the use of medical terminology alongside plain 
language during the development of a measurement instrument can be beneficial for making sure items 
are interpreted as intended and reflect the intended construct to be measured. No patients in this study 
reported concerns with this approach. 
To our knowledge, this is the first study to introduce and examine the concept of a UROM. Use of this 
method for ensuring content validity may be applicable and beneficial in a wider context. Within our 
research institution, for example, we have undertaken studies developing core outcome sets (COSs) for 
trials in oesophageal, colorectal and bariatric surgery where the views of patients and HCPs on the same 
subject were required [23-25]. A UROM, with items written in plain language and medical terminology in 
parentheses where appropriate, was used to collect the opinions of both patients and HCPs and 
prioritise outcomes of importance [23,24,26]. This concept is now recommended to COS developers as 
one approach to consider for describing outcomes to stakeholder groups [27]. Other potential 
advantages of using UROMs rather than separate questionnaires for patients and HCPs include: i) the 
need for a single study to develop the tool rather than separate studies for patient and HCPs measures; 
ii) a more streamlined and efficient way of collecting outcome data, with easier administration and 
reduced costs by using the same measure; and iii) ease of data synthesis as data from multi-
stakeholders can be readily combined.  
This study has several strengths. It is the first study, to our knowledge, to describe a UROM; an outcome 
measure intentionally developed for patient and healthcare professional completion. One-to-one 
cognitive interviews with patients and HCPs also allowed for a detailed examination of item 
comprehension and acceptability of a single tool combining plain language and medical terminology in 
both stakeholder groups. UROMs are a novel concept and, currently, their evaluation is limited to the 
 23 
 
findings from this single case study. The potential advantages of the UROM design for improving content 
validity identified in this study was an unanticipated finding, however, and was not a primary focus of 
the case-study interviews. The number of direct examples for its evaluation are, consequently, limited. 
The exact extent and nature to which medical terminology influences participants’ responses warrants 
further investigation. In Box 4, for instance, it is assumed that the respondent was clearer or more 
accurate with their response as a direct result of reading the medical term. The possibility that the 
medical term may have introduced uncertainty, ‘noise’ or measurement error was not formally 
explored. Further work to examine the applicability of UROMs to different settings would be beneficial. 
The detailed validation of the SSI outcome measure and the accuracy of the tool for assessing wound 
infection has been reported in full elsewhere [28].   
 
In summary, a novel approach to outcome assessment and development of UROMs is described. 
Findings have shown that combining plain language and medical terminology within items can improve 
content validity. It is a recommended technique for the development of outcome measures in other 
situations where information from both patients and HCPs is required. Further work is now needed to 
explore the applicability of UROMs in other settings within and outside the field of surgical research. 
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